← Back to Search

SPECT-CT for Oropharyngeal Cancer

N/A

Waitlist Available

Led By John de Almeida, M.D.

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial is testing a new way to image oropharyngeal cancer by injecting a radiotracer around the tumor.

Eligible Conditions

Oropharyngeal Cancers

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average time from start to finish of injection of procedure.

Proportion of patients completing 3 hour scan.

Proportion of patients completing 30 minute scan.

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Lymphatic drainage mapping in patients with oropharynx cancerExperimental Treatment1 Intervention

Participants will be given 4 to 6 injections of the radiotracer 99m-Technetium Sulfur Colloid by a needle into one of the veins of the radiotracer around the tumour. Participants will then have at least 1 or possibly 2 SPECT-CT scans (a special x-ray scan of the body from many angles that are turned into 3-dimensional pictures on a screen).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SPECT-CT

2016

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,507 Total Patients Enrolled

John de Almeida, M.D.Principal InvestigatorUniversity Health Network, Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we still enrolling people in this clinical trial?

"The trial is currently ongoing, as the most recent update to the listing on clinicaltrials.gov was posted on September 14th 2021. This study is looking for 18 individuals total, across a single enrolment site."

Answered by AI

How many test subjects are a part of this research?

"That is accurate. According to the listing on clinicaltrials.gov, this study was first posted on 9/13/2021 and is currently recruiting patients for 18 positions at 1 location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers

2021. "Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05055206.